Meta‐analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults

Cancer

Volumn 71, Issue 8, 1993, Pages 2585-2597

  Fine, Howard A ^a,c   Dear, Keith B G ^a   Loeffler, Jay S ^b,c   Mc Black, Peter L ^a   Canellos, George P ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

adjuvant; astrocytoma; brain tumors; chemotherapy; glioblastoma; malignant gliomas; meta analysis

Indexed keywords

ADJUVANT CHEMOTHERAPY; ARTICLE; ASTROCYTOMA; BRAIN TUMOR; CANCER SURVIVAL; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; GLIOBLASTOMA; HUMAN; MAJOR CLINICAL STUDY; META ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZATION; SURVIVAL RATE;

ADULT; ASTROCYTOMA; BRAIN NEOPLASMS; CHEMOTHERAPY, ADJUVANT; GLIOMA; HUMAN; RANDOMIZED CONTROLLED TRIALS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; SURVIVAL ANALYSIS;

EID: 0027516695     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/1097-0142(19930415)71:8<2585::AID-CNCR2820710825>3.0.CO;2-S     Document Type: Article

References (54)

1. Neurologic tumor
2. Neoplasms of the central nervous system
3. Glioblastoma multiforme (review of 219 cases with regard to natural history, pathology, diagnostic methods and treatment)
4. Assumptions in the radiotherapy of glioblastoma
5. Combined modality therapy for intracranial tumors
6. High‐dose radiation therapy in the treatment of malignant gliomas: final report
7. Radiotherapy of intracranial astrocytomas: analysis of 417 cases treated from 1960 through 1969
8. Radiation therapy of brain tumors
9. An analysis of dose‐effect relationship in the radiotherapy of malignant gliomas
10. Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas
11. Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery
12. Effectiveness of the nitrosoureas as a function of their lipid solubility in the chemotherapy of experimental rat brain tumors
13. Single‐agent chemotherapy of brain tumors: a five year review
14. Initial clinical trials with methyl‐CCNU 1‐(2–chloroethyl)‐3–(4–methyl cyclohexyl)‐I‐nitrosourea (MeCCNU)
15. Postoperative radiotherapy and radiotherapy combined with CCNU chemotherapy for treatment of brain gliomas
16. Planning the size and duration of a clinical trial studying the time to some critical event
17. The concept of an overview of cancer clinical trials with special emphasis on early breast cancer
18. Beta‐blockade during and after myocardial infarction: an overview of the randomized trials
19. Effect of intravenous streptokinase on acute myocardial infarction: pooled results from randomized trials
20. Early Breast Cancer Trialists' Collaborative Group. Effects of adjuvant Tamoxifen and of cytotoxic therapy on mortality in early breast cancer
21. The chemotherapy of brain tumors: clinical experience with carmustine (BCNU) and vincristine
22. Chloroethyl‐cyclohexyl nitrosourea (CCNU) in the treatment of malignant brain tumors
23. A phase 11 study of methylCCNU in the treatment of solid tumors and lymphomas: a Southwest Oncology Group study
24. Effect of bleomycin on brain tumors
25. Procarbazine hydrochloride in the treatment of brain tumors: phase 2 study
26. Meta‐analysis and clinical trials
27. The “file drawer problem” and tolerance for null results
28. Randomized trial of three chemotherapy regimens and two radiotherapy regimens in postoperative treatment of malignant glioma
29. Comparisons of carmustine, procarbazine, and high‐dose methylprednisone as additions to surgery and radiotherapy for the treatment of malignant glioma
30. Evaluation of prognostic factors in chemotherapy of recurrent brain tumors
31. Superiority of post‐radiotherapy adjuvant chemotherapy with CCNU, procarbazine, and vincristine (PCV) over BCNU for anaplastic gliomas: NCOG 6G61 final report
32. Phase II study of cisplatin in recurrent astrocytomas in adults: a Southwest Oncology Group Study
33. Treatment of patients with recurrent gliomas with cyclophosphamide and vincristine
34. Intravenous carboplatin for recurrent malignant glioma: a phase II study
35. Clinical patterns of failure following stereotactic interstitial irradiation for malignant gliomas
36. Controlled study of CCNU and radiation therapy in malignant astrocytoma
37. A comparison of radiotherapy alone with radiotherapy and CCNU in cerebral glioma
38. Dianhydrogalactitol and radiation therapy: treatment of supratentorial glioma
39. Controlled study with BCNU vs. CCNU as adjuvant chemotherapy following surgery plus radiotherapy for glioblastoma multiforme
40. CCNU‐chemotherapy of hemispheric glioblastoma multiforme
41. Evaluation of CCNU, VM‐26 plus CCNU, and procarbazine in supratentorial brain gliomas
42. Survival response of malignant gliomas to radiotherapy with of without BCNU or methyl‐CCNU chemotherapy at the University of Kentucky Medical Center
43. Combined modality therapy of operated astrocytomas grade 3 and 4: confirmation of the value of postoperative irradiation and lack of potentiation of bleomycin on survival time
44. Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas
45. Combined radiotherapy and chemotherapy with dibromodulcitol and CCNU in the postoperative treatment of malignant gliomas
46. Chemotherapy of malignant gliomas
47. Effects of ACNU and radiotherapy on malignant glioma
48. Histologic criteria with prognostic significance for malignant glioma
49. International histological classification of tumors, no. 21